Search research articles
Contact Us
Filters
Showing results (21-30 of 65) with videos related to
Page
of 7
Sort By:
Journal of Personalized Medicine
|
March 26, 2025
The Public Knowledge of Precision Medicine and Genomic Research: A Survey in the Aosta Valley
Matteo Mongelli, Biagio De Angelis, Valeria Delle Cave, et al.
Haematologica
|
April 30, 2025
Truncated form of human CD19 antigen as a suicide gene to control T-cell alloreactivity: ΔCD19
Simona Manni, Laura Iaffaldano, Marika Guercio, et al.
Cancer Cell International
|
April 30, 2022
FGFR1 is a potential therapeutic target in neuroblastoma
Flora Cimmino, Annalaura Montella, Matilde Tirelli, et al.
International Journal of Molecular Sciences
|
March 12, 2020
DNA Methylation Profiling for Diagnosing Undifferentiated Sarcoma with Capicua Transcriptional Receptor (<i>CIC</i>) Alterations
Evelina Miele, Rita De Vito, Andrea Ciolfi, et al.
Leukemia Research
|
August 19, 2007
Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate
Giuliana Alimena, Massimo Breccia, Luigia Luciano, et al.
Epigenomics
|
December 21, 2018
Expression profiles of exosomal miRNAs isolated from plasma of patients with desmoplastic small round cell tumor
Marta Colletti, Alessandro Paolini, Angela Galardi, et al.
Genome Biology
|
January 29, 2021
ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism
Valentina Tassinari, Valeriana Cesarini, Sara Tomaselli, et al.
Leukemia Research
|
November 28, 2013
Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia
Concetta Quintarelli, Biagio De Angelis, Santa Errichiello, et al.
Frontiers in Immunology
|
December 12, 2019
Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells
Vinicia A Polito, Rosaria Cristantielli, Gerrit Weber, et al.
Frontiers in Oncology
|
November 3, 2025
Prolonged overall survival in a child with multimetastatic retinoblastoma treated with anti-GD2 monoclonal antibody dinutuximab beta: a case report
Valentina Di Ruscio, Alessia Carboni, Giada Del Baldo, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 65) with videos related to
Sort By:
Page
of 7
Journal of Personalized Medicine
|
March 26, 2025
The Public Knowledge of Precision Medicine and Genomic Research: A Survey in the Aosta Valley
Matteo Mongelli, Biagio De Angelis, Valeria Delle Cave, et al.
Haematologica
|
April 30, 2025
Truncated form of human CD19 antigen as a suicide gene to control T-cell alloreactivity: ΔCD19
Simona Manni, Laura Iaffaldano, Marika Guercio, et al.
Cancer Cell International
|
April 30, 2022
FGFR1 is a potential therapeutic target in neuroblastoma
Flora Cimmino, Annalaura Montella, Matilde Tirelli, et al.
International Journal of Molecular Sciences
|
March 12, 2020
DNA Methylation Profiling for Diagnosing Undifferentiated Sarcoma with Capicua Transcriptional Receptor (<i>CIC</i>) Alterations
Evelina Miele, Rita De Vito, Andrea Ciolfi, et al.
Leukemia Research
|
August 19, 2007
Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate
Giuliana Alimena, Massimo Breccia, Luigia Luciano, et al.
Epigenomics
|
December 21, 2018
Expression profiles of exosomal miRNAs isolated from plasma of patients with desmoplastic small round cell tumor
Marta Colletti, Alessandro Paolini, Angela Galardi, et al.
Genome Biology
|
January 29, 2021
ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism
Valentina Tassinari, Valeriana Cesarini, Sara Tomaselli, et al.
Leukemia Research
|
November 28, 2013
Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia
Concetta Quintarelli, Biagio De Angelis, Santa Errichiello, et al.
Frontiers in Immunology
|
December 12, 2019
Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells
Vinicia A Polito, Rosaria Cristantielli, Gerrit Weber, et al.
Frontiers in Oncology
|
November 3, 2025
Prolonged overall survival in a child with multimetastatic retinoblastoma treated with anti-GD2 monoclonal antibody dinutuximab beta: a case report
Valentina Di Ruscio, Alessia Carboni, Giada Del Baldo, et al.
Page
of 7